TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, today announced the ...
Secures Exclusive Global License To Three Unleash Immuno-Oncolytics Drug Candidates. TransCode Therapeutics (NASDAQ: RNAZ) announced it has entered into an exclusive, worldwide, fully paid-up ...
Ateme, a specialist in video compression software, has entered into a multi-year agreement with Netflix for the deployment of its TITAN Live transcoder to suppo ...
It might be more than enough to keep boredom from setting in.
Add Yahoo as a preferred source to see more of our stories on Google. The trial aims to assess biological and clinical activity of TTX-MC138 in patients with MRD. Credit: Pickadook / Shutterstock.com.
Hype, scarcity, speculation and herd behavior were all hallmarks of the Tulip Mania bubble in the early 1600s. And the mania ...
A remarkably efficient way to handle two very different workloads ...
BOSTON, Feb. 5, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and ...
Featuring QCT’s OmniPOD Private 5G, AI Platforms, and Next‑generation QuantaEdge Servers Based on Intel Technologies At ...
Under the multi-year agreement, Ateme's Emmy-winning TITAN Live solution will be deployed to enhance quality and viewer ...
While major players like TCS and Infosys rely on broad platforms such as ignio or Topaz, the smarter shift is toward modular, ...
Intel is showing off some new hardware today in the form of its Xeon 6+ processors that we know better by their codename 'Clearwater Forest'.